Short Interest in VanEck Pharmaceutical ETF (NASDAQ:PPH) Grows By 26.9%

VanEck Pharmaceutical ETF (NASDAQ:PPH) saw a significant increase in short interest in November. As of November 15th, there was short interest totalling 2,360,000 shares, an increase of 26.9% from the October 31st total of 1,860,000 shares. Based on an average daily volume of 194,300 shares, the days-to-cover ratio is presently 12.1 days.

Institutional Investors Weigh In On VanEck Pharmaceutical ETF

Hedge funds have recently modified their holdings of the business. Optimum Investment Advisors bought a new stake in VanEck Pharmaceutical ETF during the 2nd quarter worth approximately $27,000. GPS Wealth Strategies Group LLC acquired a new stake in shares of VanEck Pharmaceutical ETF during the second quarter worth $42,000. CWM LLC acquired a new stake in shares of VanEck Pharmaceutical ETF during the second quarter worth $55,000. International Assets Investment Management LLC bought a new stake in VanEck Pharmaceutical ETF in the 2nd quarter valued at $86,000. Finally, Comerica Bank boosted its stake in VanEck Pharmaceutical ETF by 39.4% in the 1st quarter. Comerica Bank now owns 1,337 shares of the company’s stock worth $121,000 after purchasing an additional 378 shares during the period.

VanEck Pharmaceutical ETF Trading Up 0.1 %

Shares of VanEck Pharmaceutical ETF stock opened at $90.14 on Monday. The stock’s fifty day simple moving average is $91.95 and its 200 day simple moving average is $93.03. The company has a market capitalization of $666.13 million, a PE ratio of 21.04 and a beta of 0.72. VanEck Pharmaceutical ETF has a 12 month low of $77.61 and a 12 month high of $99.51.

VanEck Pharmaceutical ETF Company Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.